Axiall Corp (AXLL) Drops 9.79% on January 13

Equities Staff |

Axiall Corp (AXLL) was one of the Russell 2000's biggest losers for Wednesday January 13 as the stock slid 9.79% to $10.51, a loss of $-1.14 per share. Starting at an opening price of $11.73 a share, the stock traded between $10.25 and $12.12 over the course of the trading day. Volume was 1.33 million shares over 10,708 trades, against an average daily volume of 1.42 million shares and a total float of 70.58 million.

The losses send Axiall Corp down to a market cap of $741.8 million. In the last year, Axiall Corp has traded between $51.35 and $11.07, and its 50-day SMA is currently $17.27 and 200-day SMA is $27.44.

Axiall Corp is a North American manufacturer and international marketer of chemicals and building products.

Axiall Corp is based out of Atlanta, GA and has some 6,000 employees. Its CEO is Timothy Mann.

For a complete fundamental analysis analysis of Axiall Corp, check out Equities.com’s Stock Valuation Analysis report for AXLL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…